Image-guided Therapy Systems Market Size Expected to Reach US$ 7.5 Billion by 2028

PRESS RELEASE

Published April 12, 2023

According to the latest report by IMARC Group “Image-guided Therapy Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The global image-guided therapy systems market size reached US$ 5.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.5 Billion by 2028, exhibiting a growth rate (CAGR) of 6.3% during 2023-2028. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.

Image-guided therapy (IGT) systems are advanced diagnostic technologies extensively used in minimally invasive (MI) medical procedures. They facilitate the planning, execution, and evaluation of surgical techniques and therapeutic interventions. Some commonly employed IGT systems include positron emission tomography (PET), magnetic resonance imaging (MRI), computed tomography (CT) scanners, ultrasound systems, endoscopes, X-ray fluoroscopy, and portable c-arms. They provide healthcare professionals with a comprehensive, three-layered image of the affected area, enabling them to perform medical procedures with greater precision and safety. In addition, they aid in offering less invasive surgeries and more real-time treatment. As a result, image-guided therapy (IGT) systems are widely utilized in hospitals, ambulatory surgical centers, research and academic institutions, and clinics across the globe.

Request for a free sample copy of this report: https://www.imarcgroup.com/image-guided-therapy-systems-market/requestsample

Image-guided Therapy Systems Market Trends:

The market is primarily driven by the growing prevalence of chronic diseases, such as high cholesterol, cancer, high blood pressure, and cardiovascular diseases (CVDs). In addition, the increasing geriatric population, the rising popularity of minimally invasive surgeries (MIS), and escalating demand for modern clinical procedures and smart medical devices to get relevant data at the point-of-care (POC) are accelerating the product adoption rate. Moreover, the large-scale integration of radiotherapy for cancer treatment and the easy availability of angiography systems are promoting the adoption of image-guided therapy (IGT) systems. In line with this, the widespread adoption of robot-assisted endoscopic surgeries and the introduction of IGT systems that utilize imaging and specialized instruments to treat internal organs and tissues without surgical incisions are propelling the market growth. Furthermore, various initiatives undertaken by private companies for cancer treatment and the development of real-time cardiac interventions, along with ongoing collaborations between healthcare companies to improve treatment efficacy, are creating a positive market outlook.

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Product:

Ultrasound Systems
Computed Tomography (CT) Scanners
Positron Emission Tomography (PET)
Endoscopes
Magnetic Resonance Imaging (MRI)
X-ray Fluoroscopy
Others

Breakup by Application:

Cardiac Surgery
Neurosurgery
Orthopedic Surgery
Urology
Oncology Surgery
Gastroenterology
Others

Breakup by End Use:

Hospitals and Clinics
Ambulatory Surgical Centers
Research and Academic Institutions
Others

Market Breakup by Region:

North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa

Competitive Landscape:

Analogic Corporation
Brainlab AG
FUJIFILM Holdings Corporation
General Electric Company
Karl Storz SE & Co. KG
Koninklijke Philips N.V.
Medtronic plc
Siemens Healthineers AG
Stryker Corporation
Varian Medical Systems Inc

Ask Analyst for Customization and Browse full report with TOC List of Figure: https://www.imarcgroup.com/request?type=report&id=3800&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

Email: sales@imarcgroup.com

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA

Website: https://www.imarcgroup.com/

Linkedin: https://www.linkedin.com/company/imarc-group